Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-03-09 @ 2:10 PM
Study NCT ID:
NCT01773018
Status:
COMPLETED
Last Update Posted:
2016-06-01
First Post:
2013-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Sponsor:
Hutchison Medipharma Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Tumor | View |
Keywords: